SEC Form 4 research
| Issuer | CRISPR Therapeutics AG |
|---|---|
| Tickers | CRSP |
| Reporting owners | 46 |
| Officers and directors | 17 |
| Last public filing | 2026-10-15 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-15 | 2026-10-14 | KASINGER JAMES R. | S | 1,040 | $49.26 | Not reported |
| 2026-10-15 | 2026-10-14 | Kulkarni Samarth | S | 4,098 | $49.26 | Not reported |
| 2026-10-08 | 2026-10-06 | KASINGER JAMES R. | S | 1,990 | $60.04 | Not reported |
| 2026-09-24 | 2026-09-22 | KASINGER JAMES R. | S | 10,400 | $60.24 | Not reported |
| 2026-09-21 | 2026-09-17 | Behbahani Ali | S | 13,679 | $57.09 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.